+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Absence of R42X and R635X mutations in the LAMB3 gene in 12 Japanese patients with junctional epidermolysis bullosa



Absence of R42X and R635X mutations in the LAMB3 gene in 12 Japanese patients with junctional epidermolysis bullosa



Archives Of Dermatological Research. 289(3): 174-176




Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 008091302

Download citation: RISBibTeXText

PMID: 9128767

DOI: 10.1007/s004030050175


Related references

Predominance of a hotspot mutation, R635X, in the LAMB3 gene in patients with junctional epidermolysis bullosa. Journal of Investigative Dermatology 106(4): 829, 1996

Predominance of the recurrent mutation R635X in the LAMB3 gene in European patients with Herlitz junctional epidermolysis bullosa has implications for mutation detection strategy. Journal of Investigative Dermatology 109(2): 232-237, 1997

Identification of the LAMB3 hotspot mutation R635X in a Hungarian case of Herlitz junctional epidermolysis bullosa. Experimental Dermatology 6(2): 70-74, 1997

Novel mutations in the LAMB3 gene shared by two Japanese unrelated families with Herlitz junctional epidermolysis bullosa, and their application for prenatal testing. Journal of Investigative Dermatology 110(2): 174-178, 1998

Maternal germline mosaicism, LAMB3 hotspot mutation R635X and prenatal testing in Herlitz junctional epidermolysis bullosa. Journal of Investigative Dermatology 123(2), 2004

LAMB3 gene mutations in a patient with Herlitz junctional epidermolysis bullosa displaying immunoreactivity to laminin-5. Journal of Dermatological Science 16(Suppl. 1): S41, 1998

Herlitz junctional epidermolysis bullosa: novel and recurrent mutations in the LAMB3 gene and the population carrier frequency. Journal of Investigative Dermatology 115(3): 493-498, 2000

Compound heterozygosity for nonsense and missense mutations in the LAMB3 gene in nonlethal junctional epidermolysis bullosa. Journal Of Investigative Dermatology. 106(5): 1157-1159, 1996

Molecular epidemiology of junctional epidermolysis bullosa: discovery of novel and frequent LAMB3 mutations in Chilean patients with diagnostic significance. British Journal of Dermatology 176(4): 1090-1092, 2017

Junctional epidermolysis bullosa with LAMB3 splice-site mutations. Acta Dermato-Venereologica 95(7): 849-851, 2015

Digenic junctional epidermolysis bullosa: mutations in COL17A1 and LAMB3 genes. American Journal of Human Genetics 65(6): 1530-1537, 1999

Revertant mosaicism in junctional epidermolysis bullosa due to multiple correcting second-site mutations in LAMB3. Journal of Clinical Investigation 117(5): 1240-1248, 2007

Heterozygosity for premature termination codon mutations in LAMB3 in siblings with non-lethal junctional epidermolysis bullosa. Journal of Investigative Dermatology 111(6): 1244-1246, 1998

Combination of a novel frameshift mutation and a recurrent nonsense mutation of the LAMB3 gene in a Japanese patient with herlitz junctional epidermolysis bullosa, and their application for prenatal testing. Journal of Investigative Dermatology 111(6): 1239-1241, 1998

IAP insertion in the murine LamB3 gene results in junctional epidermolysis bullosa. Mammalian Genome 8(9): 673-681, 1997